ACCUTOX Trademark

Trademark Overview

On Saturday, October 21, 2017, a trademark application was filed for ACCUTOX with the United States Patent and Trademark Office. The USPTO has given the ACCUTOX trademark a serial number of 87654595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 28, 2021. The ACCUTOX trademark is filed in the Medical Instrument Products category with the following description:

Instruments, devices and apparatus for medical and surgical purposes, namely, syringes; drug delivery systems for delivering dosage of botulinum toxin and other medications or drug treatments
accutox

General Information

Serial Number87654595
Word MarkACCUTOX
Filing DateSaturday, October 21, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Goods and ServicesInstruments, devices and apparatus for medical and surgical purposes, namely, syringes; drug delivery systems for delivering dosage of botulinum toxin and other medications or drug treatments

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressBeverly Hills, CA 90210
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBeverly Hills, CA 90210

Trademark Events

Event DateEvent Description
Monday, June 28, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 28, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 25, 2020EXTENSION 5 GRANTED
Monday, November 16, 2020EXTENSION 5 FILED
Wednesday, November 25, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 16, 2020TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2020EXTENSION 4 GRANTED
Friday, May 15, 2020EXTENSION 4 FILED
Friday, May 15, 2020TEAS EXTENSION RECEIVED
Wednesday, November 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019EXTENSION 3 GRANTED
Monday, November 18, 2019EXTENSION 3 FILED
Monday, November 18, 2019TEAS EXTENSION RECEIVED
Friday, May 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 15, 2019EXTENSION 2 GRANTED
Wednesday, May 15, 2019EXTENSION 2 FILED
Wednesday, May 15, 2019TEAS EXTENSION RECEIVED
Saturday, November 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 22, 2018EXTENSION 1 GRANTED
Thursday, November 22, 2018EXTENSION 1 FILED
Thursday, November 22, 2018TEAS EXTENSION RECEIVED
Tuesday, May 22, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 16, 2018ASSIGNED TO LIE
Wednesday, January 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, January 31, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 31, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, January 31, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 31, 2018ASSIGNED TO EXAMINER
Tuesday, October 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, October 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

accutox drug botulinum dosage delivering toxin other treatments medications systems delivery